4-Methoxy-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

Catalog No. :
ACFIDR286
CAS No. :
269409-71-4
Molecular Formula :
C14H19BO5
Molecular Weight :
278.11

IUPAC Name:4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

4-Methoxy-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$74.00Login to see priceIn stockInquiry
5g96%$259.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methoxy-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
IUPAC Name4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
Molecular FormulaC14H19BO5
Molecular Weight278.11
SMILESO=C(O)C1=CC=C(OC)C(B2OC(C)(C)C(C)(C)O2)=C1
InChI KeySXVPRMHKACTQMU-UHFFFAOYSA-N
Synonym4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid;4-methoxy-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid;Benzoic acid,4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.269409-71-4
PubChem CID17924731

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACFIDR286 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTIJS647 route compound structure diagram
    ACTIJS64768507-19-7 In Stock
  2. Then
  3. ACFIDR286 route product structure diagram
    ACFIDR286269409-71-4 In Stock
Inquiry

2. ACFIDR286 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACETXO162 route compound structure diagram
    ACETXO16299-58-1 In Stock
  4. Then
  5. ACFIDR286 route product structure diagram
    ACFIDR286269409-71-4 In Stock
Inquiry

Comments (0)